Purplebricks Group PLC (LON:PURP) is the topic of conversation when Zeus Capital’s Research Director Robin Savage caught up with DirectorsTalk for an exclusive interview Q1:..
SkinBioTherapeutics PLC (LON:SBTX) CEO Dr. Catherine O’Neill talks to DirectorsTalk about passing 3rd party cellular toxicity tests. Catherine explains what was involved and what this means..
ImmuPharma PLC (LON:IMM) Non-Executive Chairman Tim McCarthy caught up with DirectorsTalk for an exclusive interview to discuss their interim results, initiating Lupuzor’s regulatory submission, activities for..
Rainbow Rare Earths Ltd (LON:RBW), the rare earth element mining company operating in East Africa, announced today its audited results for the 12 months ended 30..
Motif Bio plc (LON:MTFB), the clinical stage biopharmaceutical company specialising in developing novel antibiotics, today announced positive topline results from REVIVE-2, a global Phase 3 clinical..
OptiBiotix Health plc (LON:OPTI), a life sciences business developing compounds to tackle obesity,high cholesterol, and diabetes announced today the successful launch of its SlimBiome® and LPLDL®..
Edenville Energy plc (LON:EDL), the company developing a coal project in south west Tanzania, has today announced a subscription to raise £1.25 million (before expenses) through..
Evgen Pharma Plc (LON:EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, has today announced the grant of the..
AdEPT Telecom plc (LON:ADT) one of the UK’s leading independent providers of managed services for IT, unified communications, connectivity and voice solutions, is holding its 2017..
Ceres Power Holdings plc (LON:CWR) announced today its final results for the year ended 30 June 2017. Phil Caldwell, Ceres Power Holdings CEO, commented: “This has..
